Effects of mitragynine on cAMP formation mediated by δ-opiate receptors in NG108-15 cells

Biological and Pharmaceutical Bulletin

Volumn 20, Issue 4, 1997, Pages 338-340

  Tohda, Michihisa ^a   Thongpraditchote, Suchitra ^a   Matsumoto, Kinzo ^a   Murakami, Yukihisa ^a   Sakai, Shin Ichiro ^b   Aimi, Norio ^b   Takayama, Hiromitsu ^b   Tongroach, Pavich ^c   Watanabe, Hiroshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

antinociception; cAMP; mitragynine; NG108 15; opioid; 2 adrenoceptor

Indexed keywords

ADENYLATE CYCLASE; ALPHA 2 ADRENERGIC RECEPTOR; CYCLIC AMP; DELTA OPIATE RECEPTOR; FORSKOLIN; IDAZOXAN; MITRAGYNINE; MORPHINE; NALOXONE; NORADRENALIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINOCICEPTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; MEDICINAL PLANT; MOUSE; NONHUMAN; PLANT LEAF; RADIOIMMUNOASSAY;

EID: 0030908172     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.20.338     Document Type: Article

References (17)

1. Shellard E. J., Bull. on Narc., 26, 41-55 (1974).
2. Ponglux D., Wongseripipatana S., Takayama H., Kikuchi M., Kurihara M., Kitajima M., Aimi N., Sakai S., Planta Med., 60, 580-581 (1994).
3. Jansen K. L. R., Prast C. J., J. Psychoact. Drugs, 20, 455-157 (1988).
4. Jansen K. L. R., Prast C. J., J. Ethnopharmacol., 23, 115-119 (1988).
5. Macko E., Weisbach J. A., Duglas B., Arch. Int. Pharmacodyn., 198, 145-161 (1972).
6. Matsumoto K., Mizowaki M., Thongpradichote S., Takayama H., Sakai S., Aimi N., Watanabe H., Life Sci., 59, 1149-1155 (1996).
7. Mastumoto K., Mizowaki M., Thongpradichote S., Murakami Y., Watanabe H., Pharmacol. Biochem. Behav., in press.
8. Mastumoto K., Mizowaki M., Thongpradichote S., Murakami Y. Takayama H., Sakai S., Aimi N., Watanabe H., Eur. J. Pharmacol., 317, 75-81 (1996).
9. Mckenzine F. R., Milligan G., Biochem. J., 267, 391-398 (1990).
10. Bylund D. B., Ray-Prenger C., Murphy T. J., J. Pharm. Exp. Ther., 245, 600-607 (1988).
11. Kahn D. J., Mitrius J. C., U'Prichard D. C., Mol. Pharmacol., 21, 17-26 (1982).
12. Our unpublished data.
13. Tohda M., Imaizumi R., Sekiya A., Itoh N., Nomura Y., Biol. Pharm. Bull., 18, 1072-1075 (1995).
14. Suwanlert S., Bull. Narc., 27, 21-27 (1975).
15. Kuraishi Y., Harada Y., Satoh M., Takagi H., Neuropharmacolgy, 18, 107-110 (1979).
16. Kuraishi Y., Harada Y., Aratani S., Satoh M., Takagi H., Brain Res., 273, 245-252 (1983).
17. Zarembo J. E., Douglas B., Valenta J., Weisbach J. A., J. Pharm. Sci., 63, 1407-1415 (1974).